Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT02037802
Eligibility Criteria:
Inclusion Criteria:
* 3-12 years
* end stage renal disease
* no known allergy to bupivacaine
* both sexes
Exclusion Criteria:
* known allergy to bupivacaine
* inflammation at caudal area
* spinal cord deformity
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
12 Years
Study:
NCT02037802
Study Brief:
Protocol Section:
NCT02037802